Hemoglobin A1c measurement and standardization
31 Oct 2022

The number of people living with diabetes is rising and is projected to increase sharply around the world. Diabetes is a significant global public health challenge, that when undiagnosed, or not adequately addressed, puts people at a higher risk of life-threatening complications, such as heart attack, kidney failure, liver disease, and more.

To aid in the diagnosis and monitoring of diabetes, a patient’s hemoglobin A1c (HbA1c) is recorded over a 2–3-month period as it measures the patient’s average blood glucose levels.

Key learning objectives

After attending this webinar, participants will be able to:

  • Explain HbA1c testing and its correlation to historical diabetes patients' clinical outcomes studies
  • Describe the HbA1c standardization process and the current state of HbA1c measurements
  • Analyze potential analytical and biological interferences affecting HbA1c results

Siemens Healthineers